Plan your trading with the latest market research on Crypto, Forex, Stocks, and more, from our team of experts.
Last week started on a sour footing for crypto as the SEC filed a new lawsuit against crypto exchange Kraken…
The week for crypto started with CBOE announcing plans to launch trading and clearing in margin futures on BTC and…
Upon Bloomberg’s revelation late Wednesday night that the SEC has opened an eight-day window after 9 November to approve spot…
The price of BTC punched above its recent high of $35,500 and hit a new yearly high of $36,000 after…
Crypto prices jumped last week as the price of BTC tore through the year high of $31,800 after news that…
Exciting action in crypto started very early last week as the price of BTC did a lap dance the moment…
The price of BTC dipped last week as the worsening geopolitical situation in the middle east led to the selling…
Last week started on a weak footing for crypto as the new ETH futures ETF trading started without much fanfare…
Despite US lawmakers’ pressure on the SEC to approve spot BTC ETFs immediately, the SEC did not relent last week….
More institutional participation in crypto was announced last week, as news of Nomura and Citi Group both launching crypto products…
Following news that investment behemoth Franklin Templeton Investments have also filed a spot BTC ETF application last week, sentiment in…
Following rumors that both the SEC and the FBI are launching investigations into Digital Currency Group (DCG), the crypto market…
The crypto market started on a strong footing last week, led by several key positive news. First, according to a…
The week in crypto started with yet another Binance FUD, with the latest installment alleging Binance of selling their BTC…
The information provided here is not an invitation to buy or sell products, nor is it an invitation to make an investment or trading strategy. This should not be seen as financial or investment advice of any kind, nor does Prime XBT endorse or guarantee the relevance, timeliness, or accuracy of the information or publications.
Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.
